Schedule 13G ownership disclosure

SCINAI IMMUNOTHERAPEUTICS LT

Security class unavailable · CUSIP: 09073Q204

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001567619-23-001890
Form type
SC 13G/A
Filer
Scinai Immunotherapeutics Ltd.
CIK
CIK 1611747
Filed
Feb 06, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub